Back
Sangamo Therapeutics Vs. Protalix BioTherapeutics Industry Stock Comparison
Sell
29
SGMO
Sangamo Therapeutics
Last Price:
0.55
Seasonality Move:
-2.28%
Sell
34
PLX
Protalix BioTherapeutics
Last Price:
1.15
Seasonality Move:
-3.41%
Sell
29
Sangamo Therapeutics (SGMO)
is a Sell
Is Sangamo Therapeutics a Buy, Sell or Hold?
- The current Sangamo Therapeutics [SGMO] share price is $0.52. The Score for SGMO is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- SGMO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Protalix BioTherapeutics (PLX)
is a Sell
Is Protalix BioTherapeutics a Buy, Sell or Hold?
- The current Protalix BioTherapeutics [PLX] share price is $1.16. The Score for PLX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- PLX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SGMO Stock Price Chart
What is Sangamo Therapeutics's stock price today?
-
The Sangamo Therapeutics share price today is $0.52
The current trend is relatively stagnant and SGMO is experiencing selling pressure, which indicates risk of future bearish movement.
PLX Stock Price Chart
What is Protalix BioTherapeutics's stock price today?
-
The Protalix BioTherapeutics share price today is $1.16
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLX is experiencing selling pressure, which indicates risk of future bearish movement.
SGMO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 42.31 | Sell |
| Chaikin Money Flow: | -556565 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.5 - 0.58) | Sell |
| Bollinger Bands (100): | (0.41 - 0.87) | Sell |
PLX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 44.02 | Sell |
| Chaikin Money Flow: | -218873 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.15 - 1.25) | Sell |
| Bollinger Bands (100): | (1.26 - 1.66) | Sell |
SGMO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.52 | Buy |
| 20-day SMA: | 0.53 | Sell |
| 50-day SMA: | 0.73 | Sell |
| 200-day SMA: | 0.69 | Sell |
| 8-day EMA: | 0.52 | Sell |
| 20-day EMA: | 0.55 | Sell |
| 50-day EMA: | 0.62 | Sell |
| 200-day EMA: | 0.91 | Sell |
PLX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.18 | Sell |
| 20-day SMA: | 1.19 | Sell |
| 50-day SMA: | 1.31 | Sell |
| 200-day SMA: | 1.55 | Sell |
| 8-day EMA: | 1.18 | Sell |
| 20-day EMA: | 1.2 | Sell |
| 50-day EMA: | 1.29 | Sell |
| 200-day EMA: | 1.52 | Sell |
Sangamo Therapeutics Earnings Growth & SGMO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.92 per share, and an increase next year of $0.53 per share.
Protalix BioTherapeutics Earnings Growth & PLX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sangamo Therapeutics Technical Analysis
| Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Protalix BioTherapeutics Technical Analysis
| Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||